Kiora Pharmaceuticals Inc. (KPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,835 | -4,319 | -4,345 | -2,193 | 3,595 |
| Depreciation Amortization | 25 | 14 | 4 | 0 | 123 |
| Income taxes - deferred | -389 | N/A | N/A | N/A | -289 |
| Accounts payable and accrued liabilities | 1,125 | 469 | 510 | 1,172 | 226 |
| Other Working Capital | -3,270 | -2,916 | -2,589 | -262 | 3,666 |
| Other Operating Activity | 3,383 | -1,029 | -87 | -1,421 | 1,238 |
| Operating Cash Flow | $-9,961 | $-7,781 | $-6,508 | $-2,704 | $8,559 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -111 | -33 | -32 | N/A | -6 |
| Purchase Of Investment | -8,176 | -8,176 | -8,176 | -3,619 | -35,632 |
| Sale Of Investment | 22,713 | 17,286 | 11,545 | 6,292 | 12,976 |
| Investing Cash Flow | $14,427 | $9,078 | $3,337 | $2,673 | $-22,663 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,750 | N/A | N/A | N/A | N/A |
| Debt Issued | N/A | 2,750 | N/A | N/A | N/A |
| Debt Repayment | N/A | -2,750 | N/A | N/A | N/A |
| Common Stock Issued | 266 | 265 | 265 | 0 | 1,689 |
| Other Financing Activity | -2,750 | 0 | 0 | 0 | 13,809 |
| Financing Cash Flow | $266 | $265 | $265 | $0 | $15,498 |
| Exchange Rate Effect | 174 | 155 | 142 | 10 | -57 |
| Beginning Cash Position | 3,796 | 3,796 | 3,796 | 3,796 | 2,459 |
| End Cash Position | 8,701 | 5,513 | 1,033 | 3,775 | 3,796 |
| Net Cash Flow | $4,905 | $1,717 | $-2,764 | $-21 | $1,337 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,961 | -7,781 | -6,508 | -2,704 | 8,559 |
| Capital Expenditure | -111 | -33 | -32 | N/A | -6 |
| Free Cash Flow | -10,072 | -7,813 | -6,540 | -2,704 | 8,553 |